EG 427 Announces Positive Preclinical Results from EG110A IND-Enabling Study in Neurogenic Detrusor Overactivity and Overactive Bladder

November 06, 2023

EG 427 today reports positive preclinical results from a dose escalation study of its gene therapy product EG110A for the treatment of neurogenic detrusor overactivity (NDO) and overactive bladder (OAB). The data represents a pivotal milestone and paves the way for an Investigational New Drug (IND) application and initiation of the first clinical study of EG110A in early 2024.

Access full Press Release in English and in French.

< back

Recent posts

EG 427 Announces Attendance at Conferences in H1 2024
EG 427 Announces Attendance at Conferences in H1 2024

read more >

EG 427 Announces New Preclinical Results from Multiple Studies of EG110A in NDO and OAB
EG 427 Announces New Preclinical Results from Multiple Studies of EG110A in NDO and OAB

read more >

EG 427 Appoints Don Haut, Ph.D as Chief Business Officer and Opens US Headquarters
EG 427 Appoints Don Haut, Ph.D as Chief Business Officer and Opens US Headquarters

read more >

EG 427 to hold poster presentation on lead asset EG110A at ESGCT
EG 427 to hold poster presentation on lead asset EG110A at ESGCT

read more >

EG 427 announces attendance to multiple upcoming conferences in fall 2023
EG 427 announces attendance to multiple upcoming conferences in fall 2023

read more >

×

By clicking Consent, you accept the saving of all cookie data on your device. If you click Denied, only the data necessary for the website to function is saved. More information about cookies in the privacy policy.

settings Reject I agree
×

Essential Cookies

These cookies are necessary for the website to function and cannot be turned off. They are used, for example, to maintain the contents of the user's basket. You can set your browser to block these cookies, but then the website will not function prope

Always active

Analytical cookies

These cookies allow you to count visits and traffic sources. Thanks to these files, it is known which pages are more popular and how the website visitors navigate. All information these cookies collect is anonymous.